Back to AVBP

WELLINGTON MANAGEMENT GROUP LLP → AVBP

WELLINGTON MANAGEMENT GROUP LLP AVBP Position History

ArriVent BioPharma, Inc. • Healthcare

Quarters held
12
Latest value
$2.4M
Q3 2026
Peak value
$2.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$472K
Q4 2025$74K
Q4 2025$1.1M
Q1 2026$553K
Q1 2026$85K
Q1 2026$1.2M
Q2 2026$1.1M
Q2 2026$153K
Q2 2026$2.2M
Q3 2026$1.4M
Q3 2026$230K
Q3 2026$2.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.4M78.7K——
Q3 2026$230K7.6K——
Q3 2026$1.4M47.5K——
Q2 2026$2.2M64.4K——
Q2 2026$153K4.4K——
Q2 2026$1.1M32.0K——
Q1 2026$1.2M50.6K——
Q1 2026$85K3.7K——
Q1 2026$553K24.0K——
Q4 2025$1.1M55.1K——
Q4 2025$74K3.7K——
Q4 2025$472K23.5K——

Other funds holding AVBP

Other WELLINGTON MANAGEMENT GROUP LLP positions

NVDA

NVIDIA CORPORATION

$23.3B
MSFT

MICROSOFT CORP

$23.2B
NVDA

NVIDIA CORPORATION

$22.3B
NVDA

NVIDIA CORPORATION

$20.9B
MSFT

MICROSOFT CORP

$20.4B
NVDA

NVIDIA CORPORATION

$20B
AAPL

APPLE INC

$18.2B
AAPL

APPLE INC

$18.2B
WELLINGTON MANAGEMENT GROUP LLP AVBP Holdings: 13F Position History | Track13F